Paul Griffiths

University College London — United Kingdom

Medicine · Health Sciences

75h-index21.7kcitations701works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytomegalovirus and herpesvirus research(261), Herpesvirus Infections and Treatments(170), Parvovirus B19 Infection Studies(88), HIV Research and Treatment(47), Viral-associated cancers and disorders(40)

Publications699 total

Cross-herpesvirus immunity of the cytomegalovirus gB/MF59 vaccine response
npj Vaccines·2025Open Access
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Vaccines·2025· 7 citedOpen Access
Corruption need not always be unethical
SPIRE - Sciences Po Institutional REpository·2024
List of Abbreviations
2024
Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial
The Journal of Pediatrics·2024· 27 citedOpen Access
Persistent Low-Level Variants in a Subset of Viral Genes Are Highly Predictive of Poor Outcome in Immunocompromised Patients With Cytomegalovirus Infection
The Journal of Infectious Diseases·2024· 2 citedOpen Access
Vaccine value profile for cytomegalovirus
Vaccine·2023· 30 citedOpen Access
Genomic and geographical structure of human cytomegalovirus
Proceedings of the National Academy of Sciences·2023· 27 citedOpen Access
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients’ sera
Journal of General Virology·2023Open Access
Enabling Responsible Banking through the Application of Blockchain
Journal of Innovation Economics & Management·2023· 14 citedOpen Access
Control of human cytomegalovirus replication by liver resident natural killer cells
Nature Communications·2023· 21 citedOpen Access
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread
Nature Communications·2023· 29 citedOpen Access
Oral Valganciclovir Initiated Beyond One Month of Age for the Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection
SSRN Electronic Journal·2023Open Access
Persistent low-level variants in a subset of HCMV genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection
2022· 2 citedOpen Access
Haplotype assignment of longitudinal viral deep sequencing data using covariation of variant frequencies
Virus Evolution·2022· 12 citedOpen Access
Issue Information
Transfusion Medicine·2022Open Access
Impact of COVID-19 on drug markets, use, harms and drug services in Europe
Journal of Geography Politics and Society·2022Open Access
Control of human cytomegalovirus replication by liver resident natural killer cells
Research Square (Research Square)·2022· 1 citedOpen Access
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre
Transfusion Medicine·2022· 6 citedOpen Access
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
Nature Communications·2022· 96 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Vincent C. Emery(15), Claire Atkinson(6), Caroline Sabin(5), Duncan A. Clark(5), Per Ljungman(4), Aycan F. Hassan‐Walker(4), Alethea Cope(4), Andrew K. Burroughs(4), Robert F. Pass(4), Colette Smith(3), Matthew B. Reeves(3), Charles Cunningham(3), Derrick J. Dargan(3), Gavin W. G. Wilkinson(3), Andrew J. Davison(3), R Milne(3), J. E. Grundy(3), Hoe Nam Leong(3), Jane R Deayton(3), Pauline Wilson(3)